Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic AIDS drugs

Executive Summary

Merck grants license to South African firm for a generic version of the AIDS drug Sustiva, but it is unclear whether efavirenz can be produced "at a price that is at or below the Merck no-profit price," Merck exec says during a conference sponsored by the American Enterprise Institute in Washington, D.C. May 12. FDA is working on a guidance on a streamlined approval process for generic AIDS treatments used in developing countries...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS043972

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel